Relmada Therapeutics (RLMD) Notes Payables (2014 - 2019)
Relmada Therapeutics' (RLMD) quarterly Notes Payables came in at $110247.0 in Q4 2019, down 3.91% year-on-year from $114738.0 in Q4 2018, and down 56.92% on a QoQ basis from $255925.0 in Q3 2019.
Relmada Therapeutics (RLMD) Notes Payables (2014 - 2019) Analysis & Trends
Relmada Therapeutics (RLMD) has 6 years of Notes Payables data on file, last reported at $110247.0 in Q4 2019.
- On a quarterly basis, Notes Payables fell 3.91% year-over-year to $110247.0 in Q4 2019; TTM through Dec 2019 was $110247.0, a 3.91% decrease from a year earlier, with the FY2019 full-year figure at $110247.0, changed N/A from the prior year.
- Notes Payables for Q4 2019 stood at $110247.0, down from $255925.0 in the prior quarter.
- Over the last five years, Notes Payables for RLMD reached as high as $24.5 million in Q1 2015 and fell as low as $27880.0 in Q1 2018.
- Historically, Notes Payables has averaged $2.6 million across 5 years, with a median of $282300.0 in 2017.
- On a YoY basis, Notes Payables climbed as much as 23892.61% in 2015 and fell as far as 99.67% in 2015.
- Year by year, Notes Payables stood at $88533.0 in 2015, then surged by 491.31% to $523505.0 in 2016, then jumped by 603.62% to $3.7 million in 2017, then plunged by 96.89% to $114738.0 in 2018, then retreated by 3.91% to $110247.0 in 2019.
- Per Business Quant data, the three most recent Notes Payables figures were $110247.0 in Q4 2019, $255925.0 in Q3 2019, and $364204.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 110,247.00 |
| Sep 30, 2019 | 255,925.00 |
| Jun 30, 2019 | 364,204.00 |
| Mar 31, 2019 | 28,769.00 |
| Dec 31, 2018 | 114,738.00 |
| Sep 30, 2018 | 4.51 Mn |
| Jun 30, 2018 | 285,170.00 |
| Mar 31, 2018 | 27,880.00 |
| Dec 31, 2017 | 3.68 Mn |
| Sep 30, 2017 | 194,164.00 |
| Jun 30, 2017 | 175,853.00 |
| Mar 31, 2017 | 279,430.00 |
| Dec 31, 2016 | 523,505.00 |
| Sep 30, 2016 | 972,546.00 |
| Jun 30, 2016 | 892,503.00 |
| Mar 31, 2016 | 614,079.00 |
| Dec 31, 2015 | 88,533.00 |
| Sep 30, 2015 | 176,448.00 |
| Jun 30, 2015 | 14.00 Mn |
| Mar 31, 2015 | 24.47 Mn |